Search   
MSDS  : L-Ascorbic acid
CAS  : 50-81-7
SYNONYMS  : * Adenex * Allercorb * Antiscorbic vitamin * Antiscorbutic vitamin * Arco-cee * Ascoltin * Ascorbajen * Ascorbate * Ascorbic acid * L(+)-Ascorbic acid * Ascor-B.I.D. * Ascorbutina * Ascorin * Ascorteal * Ascorvit * Cantan * Cantaxin * Catavin C * Cebicure * Cebid * Cebion * Cebione * Cecon * Cee-caps TD * Cee-vite * Cegiolan * Ceglion * Celaskon * ce lent * Celin * Cemagyl * Ce-Mi-Lin * Cemill * Cenetone * Cereon * Cergona * Cescorbat * Cetamid * Cetane-caps TD * Cetemican * Cevalin * Cevatine * Cevex * Cevi-bid * Cevimin * CE-VI-Sol * Cevital * Cevitamic acid * Cevitamin * Cevitan * Cevitex * Cewin * Ciamin * Cipca * Citriscorb * C-Level * C-Long * Colascor * Concemin * C-Quin * C-Span * C-Vimin * Dora-C-500 * Davitamon C * Duoscorb * L-threo-Hex-2-enonic acid, gamma-lactone * Hicee * Hybrin * IDO-C * 3-Keto-L-gulofuranolactone * L-3-Ketothreohexuronic acid lactone * Kyselina askorbova * Laroscorbine * Lemascorb * Liqui-Cee * L-Lyxoascorbic acid * NCI-C54808 * NSC 33832 * 3-Oxo-L-gulofuranolactone * 3-Oxo-L-gulofuranolactone (enol form) * Planavit C * Proscorbin * Redoxon * Ribena * Roscorbic * Scorbacid * Scorbu-C * Secorbate * Testascorbic * Vicelat * Vicomin C * Viforcit * Viscorin * Vitace * Vitacee * Vitacimin * Vitacin * Vitamin C * Vitamisin * Vitascorbol * Xitix * L-Xyloascorbic acid
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : CI7650000
CHEMICAL NAME : L-Ascorbic acid
CAS REGISTRY NUMBER : 50-81-7
OTHER CAS REGISTRY NOS. : 129940-97-2
89924-69-6
57606-40-3
30208-61-8
14536-17-5
57304-74-2
56533-05-2
50976-75-5
LAST UPDATED : 199707
DATA ITEMS CITED : 46
MOLECULAR FORMULA : C6-H8-O6
MOLECULAR WEIGHT : 176.14
WISWESSER LINE NOTATION : T5OV EHJ CQ DQ EYQ1Q
COMPOUND DESCRIPTOR : Tumorigen
Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Adenex
* Allercorb
* Antiscorbic vitamin
* Antiscorbutic vitamin
* Arco-cee
* Ascoltin
* Ascorbajen
* Ascorbate
* Ascorbic acid
* L(+)-Ascorbic acid
* Ascor-B.I.D.
* Ascorbutina
* Ascorin
* Ascorteal
* Ascorvit
* Cantan
* Cantaxin
* Catavin C
* Cebicure
* Cebid
* Cebion
* Cebione
* Cecon
* Cee-caps TD
* Cee-vite
* Cegiolan
* Ceglion
* Celaskon
* ce lent
* Celin
* Cemagyl
* Ce-Mi-Lin
* Cemill
* Cenetone
* Cereon
* Cergona
* Cescorbat
* Cetamid
* Cetane-caps TD
* Cetemican
* Cevalin
* Cevatine
* Cevex
* Cevi-bid
* Cevimin
* CE-VI-Sol
* Cevital
* Cevitamic acid
* Cevitamin
* Cevitan
* Cevitex
* Cewin
* Ciamin
* Cipca
* Citriscorb
* C-Level
* C-Long
* Colascor
* Concemin
* C-Quin
* C-Span
* C-Vimin
* Dora-C-500
* Davitamon C
* Duoscorb
* L-threo-Hex-2-enonic acid, gamma-lactone
* Hicee
* Hybrin
* IDO-C
* 3-Keto-L-gulofuranolactone
* L-3-Ketothreohexuronic acid lactone
* Kyselina askorbova
* Laroscorbine
* Lemascorb
* Liqui-Cee
* L-Lyxoascorbic acid
* NCI-C54808
* NSC 33832
* 3-Oxo-L-gulofuranolactone
* 3-Oxo-L-gulofuranolactone (enol form)
* Planavit C
* Proscorbin
* Redoxon
* Ribena
* Roscorbic
* Scorbacid
* Scorbu-C
* Secorbate
* Testascorbic
* Vicelat
* Vicomin C
* Viforcit
* Viscorin
* Vitace
* Vitacee
* Vitacimin
* Vitacin
* Vitamin C
* Vitamisin
* Vitascorbol
* Xitix
* L-Xyloascorbic acid

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - man
DOSE/DURATION : 2300 mg/kg/2D
TOXIC EFFECTS :
Blood - oxidant related (GPD deficient) anemia
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200
Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year:
82,810,1975

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 900 mg/kg
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
REFERENCE :
AIMDAP Archives of Internal Medicine. (AMA, 535 N. Dearborn St., Chicago,
IL 60610) V.1- 1908- Volume(issue)/page/year: 145,950,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11900 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation
Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,131,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,131,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,131,1976

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3367 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary,
Developmental Therapeutics Program. (Bethesda, MD 20205)
Volume(issue)/page/year: JAN1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 643 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year:
1,682,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 518 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RPOBAR Research Progress in Organic-Biological and Medicinal Chemistry. (New
York, NY) V.1-3, 1964-72. Discontinued. Volume(issue)/page/year:
2,269,1970

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 546 gm/kg/13W-I
TOXIC EFFECTS :
Related to Chronic Data - death
REFERENCE :
NTPTR* National Toxicology Program Technical Report Series. (Research
Triangle Park, NC 27709) No.206- Volume(issue)/page/year: NTP-TR-247,1983

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 2500 mg/kg
SEX/DURATION : female 1-22 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
AJANA2 American Journal of Anatomy. (Alan R. Liss, Inc., 41 E. 11th St.,
New York, NY 10003) V.1-192, 1901-91. Volume(issue)/page/year: 110,29,1962

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE : 6680 mg/kg
SEX/DURATION : female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year:
64,423,1990

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE : 800 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 8,175,1961

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - guinea pig
DOSE : 19500 mg/kg
SEX/DURATION : female 30-58 day(s) after conception
lactating female 10 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
ANYAA9 Annals of the New York Academy of Sciences. (New York Academy of
Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877-
Volume(issue)/page/year: 258,401,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - guinea pig
DOSE : 5800 mg/kg
SEX/DURATION : female 1-58 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
REFERENCE :
BEXBAN Bulletin of Experimental Biology and Medicine (English Translation).
Translation of BEBMAE. (Plenum Pub. Corp., 233 Spring St., New York, NY
10013) V.41- 1956- Volume(issue)/page/year: 57,483,1964

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - guinea pig
DOSE : 2471 mg/kg
SEX/DURATION : multigenerations
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
ANYAA9 Annals of the New York Academy of Sciences. (New York Academy of
Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877-
Volume(issue)/page/year: 258,465,1975

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 500 ug/plate
REFERENCE :
ABCHA6 Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050,
Tokyo International, Tokyo 100-31, Japan) V.25- 1961-
Volume(issue)/page/year: 45,327,1981

TYPE OF TEST : DNA damage
TEST SYSTEM : Bacteria - Bacillus subtilis
DOSE/DURATION : 2 mg/disc
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year:
1,175,1981

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Microorganism - not otherwise specified
DOSE/DURATION : 1000 ppm
REFERENCE :
POASAD Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of
Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State
Univ., Weatherford, OK 73096) V.1- 1910/1920- Volume(issue)/page/year:
34,114,1953

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Mold - Neurospora crassa
DOSE/DURATION : 2 mmol/L
REFERENCE :
MAGDA3 Mechanisms of Ageing and Development. (Elsevier Science Pub. Co.,
Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1972-
Volume(issue)/page/year: 10,249,1979

TYPE OF TEST : DNA repair
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 100 mg/L
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year:
1,502,1981

TYPE OF TEST : Gene conversion and mitotic recombination
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 300 mg/L
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year:
1,491,1981

TYPE OF TEST : Sex chromosome loss and nondisjunction
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 100 mg/L
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52
Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year:
1,468,1981

TYPE OF TEST : Sperm Morphology
ROUTE OF EXPOSURE : Parenteral
TEST SYSTEM : Insect - silkworm
DOSE/DURATION : 25 ug
REFERENCE :
EISOAU Eiyo to Shokuryo. Food and Nutrition. (Tokyo, Japan) V.10-35,
1957-82. Volume(issue)/page/year: 34,367,1981

TYPE OF TEST : DNA damage
TEST SYSTEM : Human Fibroblast
DOSE/DURATION : 200 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3783,1982

TYPE OF TEST : DNA damage
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 200 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3783,1982

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human HeLa cell
DOSE/DURATION : 2500 umol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 92,427,1982

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 200 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3783,1982

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Human Fibroblast
DOSE/DURATION : 200 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3783,1982

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 200 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
42,3783,1982

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 200 mg/L
REFERENCE :
ONCOBS Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21-
1967- Volume(issue)/page/year: 35,160,1978

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 4500 mg/kg/3D (Continuous)
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
21,160,1993

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Liver
DOSE/DURATION : 500 umol/L
REFERENCE :
JNSVA5 Journal of Nutritional Science and Vitaminology. (Business Center
for Academic Soc. Japan, 2-4-16 Yayoi, Bunkyo-ku, Tokyo 113, Japan) V.19-
1973- Volume(issue)/page/year: 24,263,1978

TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 1600 mg/kg
REFERENCE :
TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc.,
41 E. 11th St., New York, NY 10003) V.1- 1980- Volume(issue)/page/year:
9,51,1989

TYPE OF TEST : Sister chromatid exchange
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 1600 mg/kg
REFERENCE :
TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc.,
41 E. 11th St., New York, NY 10003) V.1- 1980- Volume(issue)/page/year:
9,51,1989

TYPE OF TEST : Micronucleus test
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 400 mg/L
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year:
26,240,1995

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 300 mg/L
REFERENCE :
FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For
publisher information, see FCTOD7. Volume(issue)/page/year: 18,497,1980

TYPE OF TEST : Sister chromatid exchange
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 500 mg/L
REFERENCE :
SCIEAS Science. (American Assoc. for the Advancement of Science, 1333 H
St., NW, Washington, DC 20005) V.1- 1895- Volume(issue)/page/year:
236,933,1987

TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 500 umol/L
REFERENCE :
JNSVA5 Journal of Nutritional Science and Vitaminology. (Business Center
for Academic Soc. Japan, 2-4-16 Yayoi, Bunkyo-ku, Tokyo 113, Japan) V.19-
1973- Volume(issue)/page/year: 24,263,1978

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - M0462
No. of Facilities: 5030 (estimated)
No. of Industries: 24
No. of Occupations: 33
No. of Employees: 69440 (estimated)

NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - M0462
No. of Facilities: 7888 (estimated)
No. of Industries: 41
No. of Occupations: 56
No. of Employees: 137698 (estimated)
No. of Female Employees: 84231 (estimated)

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-human lymphocytes; In vitro
SCE-human

EPA GENETOX PROGRAM 1988, Positive: In vitro SCE-nonhuman

EPA GENETOX PROGRAM 1988, Negative: Sperm morphology-mouse

EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; Histidine
reversion-Ames test

EPA TSCA Section 8(b) CHEMICAL INVENTORY

NTP Carcinogenesis Bioassay (feed);no evidence:mouse,rat
NTPTR* National Toxicology Program Technical Report Series. (Research
Triangle Park, NC 27709) No.206- Volume(issue)/page/year: NTP-TR-247,83


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Asafoetida, hydrogen sulfate, sodium salt 9000-04-8
Asarum canadense var. reflexum extracts 9000-04-8
Asarum heterotropoides FR. schmidt var. mandshuricum,extract 9000-04-8
Asarum himalaicum Hook. F. et Thoms, extract 9000-04-8
Asarum ichangense C. Y. cheng ET C. S. yang, extract 9000-04-8
Asbestos 1332-21-4
Asbestos, actinolite 77536-66-4
Asbestos, amosite 12172-73-5
Antibiotic X-29-C 102648-28-2
Asbestos, anthophyllite 77536-67-5
Asbestos, chrysotile 12001-29-5
Asbestos, crocidolite 12001-28-4
Asbestos, tremolite 77536-68-6
AscaricidinSUBSTANCE DEFINITION :Isolated from Streptomyces hachijoensisREFERENCE :85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., BocaRaton, FL, CRC Press, 1980- 77536-68-6
Ascelpias currassavica Linn., extract 77536-68-6
Ascleposide 3080-19-1
Ascomycin 11011-38-4
L-Ascorbic acid 50-81-7
L-Ascorbic acid, 2-amino-2-deoxy- 32764-43-5
Antibiotic X 14873C 88384-86-5
L-Ascorbic acid, compd. with 2-aminoethanethiol (11) 16031-82-6
L-Ascorbic acid, compd. with N(sup4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-1,4-pentanediamine (2:1) 38305-48-5
Ascorbic acid mixed with copper sulfate (11) 38305-48-5
L-Ascorbic acid,2-(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1- benzopyran-6-yl hydrogen phosphate),monosodium salt 132746-07-7
D-Ascorbic acid, compd. with3,4-dihydroxy-alpha-((methylamino)methyl)benzylalcohol 132746-07-7
L-Ascorbic acid, compd. with3,4-dihydroxy-alpha-((methylamino)methyl)benzylalcohol 134-17-8
Ascorbic acid, L- and glycine, reaction mixture 134-17-8
L-Ascorbic acid, 2-hydrogensulfate (ester) 134-17-8
L-Ascorbic acid, monosodium salt 134-03-2
L-Ascorbic acid, monosodium salt, 2-sodium sulfate,dihydrate 134-03-2
Antibiotic X 14873D 88385-02-8
L-Ascorbic acid, 2,3-O-(2-oxopropylidene)- 74717-64-9
L-Ascorbic acid, 6-palmitate 137-66-6
Ascorbic acid, L- and DL-phenylalanine, reactionmixture 137-66-6
L-Ascorbic acid, 6-stearate 10605-09-1
Ascorbic acid, L- and L-tryptophan, reaction mixture 10605-09-1
Ascosin 1402-88-6
Ascosin A 102648-34-0
Ascosin B 102648-35-1
Asebotoxin V, bisdeacyl- 56663-60-6
Asgen 56663-60-6
Antibiotic XK 46 50813-46-2
Asgen-C 50813-46-2
Asgen syrup A 50813-46-2
ASK (Oil additive) 39421-56-2
L-Asparaginase 9015-68-3
L-Asparaginase, from erwinia carotovora 9015-68-3
L-Asparagine, N(sup 2)-acetyl-,1-((3-hexyl-4-oxo-2-oxetanyl)methyl)-3,6-dodecadienylester, (2S-(2-alpha(1R*,3Z,6Z),3-beta))- 67655-93-0
Asparagine, N(sup 2)-benzyl-N,N-diethyl-, DL- 25800-54-8
Asparagine, N,N(sup 2)-dibenzyl-, DL- 25800-55-9

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net